Avita Medical
1st Floor, Unex House
132-134 Hills Road
Cambridge
CB2 8PA
United Kingdom
Tel: 44-0-1223 341150
Fax: 44-0-1223-341170
Website: http://www.avitamedical.com/
Email: info.eu@avitamedical.com
267 articles about Avita Medical
-
Avita Medical Presents More Positive ReCell Repigmentation Trial Results
6/11/2014
-
Avita Medical Appoints New Chairman
5/20/2014
-
FDA Release: Avita Medical Grants An Investigational Device Exemption For Compassionate Use Of ReCell
4/10/2014
-
Avita Medical Release: ReCell Containing Ambient-Stored Enzyme Launched In United Kingdom And Europe
4/9/2014
-
Avita Medical CEO Steps Down After First Strike, Interim Chief Named
12/12/2013
-
Avita Medical Announces Completion of Enrollment in ReCell® Trial for Vitiligo
8/21/2013
-
Avita Medical Enrolls First Patients in ReCell® Trial for Chronic Leg Ulcers
8/1/2013
-
Avita Medical Release: Granted Japanese Patent Expands Commercial Rights for ReCell® Spray-On Skin® Technology in Asia
4/10/2013
-
Avita Medical Skin Regeneration Symposium Attracts Top European Surgeons
3/28/2013
-
Avita Medical Completes ISO Quality Audit, CE Mark Recertification
2/14/2013
-
Avita Medical CEO William Dolphin, Ph.D. Interviewed by Stock News Now
2/14/2013
-
Avita Medical Appoints Dr. Michael S. Perry to Board of Directors
2/7/2013
-
Avita Medical Initiates European Trial Using ReCell in the Management of Chronic Lower Limb Ulcers
11/20/2012
-
Avita Medical to Present at SoCalBio Investor Conference & Exhibition
11/5/2012
-
Avita Medical Strengthens Board
10/23/2012
-
Avita Medical Release: $10.2 Million Capital Raising Oversubscribed
10/23/2012
-
Avita Medical Secures Additional Funding From U.S. Department of Defense
10/1/2012
-
Avita Medical Announces ReCell Presentations at the 16th Congress of the International Society for Burn Injuries (ISBI)
9/12/2012
-
Cornerstone Institutional Investors Head Avita Medical 's $10 Million Capital Raising
9/10/2012
-
Avita Medical Announces Manufacturing Advances
8/28/2012